These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33051144)

  • 1. Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study.
    Hirashima T; Arai T; Kitajima H; Tamura Y; Yamada T; Hashimoto S; Morishita H; Minamoto S; Kawashima K; Kashiwa Y; Kameda M; Takeshita T; Suzuki H; Matsuoka H; Yamaguchi S; Tanaka T; Nagai T
    J Infect Chemother; 2021 Jan; 27(1):76-82. PubMed ID: 33051144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.
    Dastan F; Saffaei A; Haseli S; Marjani M; Moniri A; Abtahian Z; Abedini A; Kiani A; Seifi S; Jammati H; Hashemian SMR; Pourabdollah Toutkaboni M; Eslaminejad A; Heshmatnia J; Sadeghi M; Nadji SA; Dastan A; Baghaei P; Varahram M; Yousefian S; Salamzadeh J; Tabarsi P
    Int Immunopharmacol; 2020 Nov; 88():106869. PubMed ID: 32889241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
    Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E
    J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence.
    Ren HW; Wu Y; Dong JH; An WM; Yan T; Liu Y; Liu CC
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8210-8218. PubMed ID: 32767351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
    Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
    Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early predictors for mechanical ventilation in COVID-19 patients.
    Li W; Lin F; Dai M; Chen L; Han D; Cui Y; Pan P
    Ther Adv Respir Dis; 2020; 14():1753466620963017. PubMed ID: 33054630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab treatment in COVID-19: A single center experience.
    Luo P; Liu Y; Qiu L; Liu X; Liu D; Li J
    J Med Virol; 2020 Jul; 92(7):814-818. PubMed ID: 32253759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
    Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
    Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Predictors of Poor Prognosis among Critical COVID-19 Pneumonia Patients Requiring Tracheal Intubation.
    Kishaba T; Maeda A; Nabeya D; Nagano H
    Tohoku J Exp Med; 2020 Oct; 252(2):103-107. PubMed ID: 32938838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT Quantitative Analysis and Its Relationship with Clinical Features for Assessing the Severity of Patients with COVID-19.
    Sun D; Li X; Guo D; Wu L; Chen T; Fang Z; Chen L; Zeng W; Yang R
    Korean J Radiol; 2020 Jul; 21(7):859-868. PubMed ID: 32524786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19.
    Chen X; Yan L; Fei Y; Zhang C
    J Clin Lab Anal; 2020 Oct; 34(10):e23467. PubMed ID: 32656888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of 82 cases of death from COVID-19.
    Zhang B; Zhou X; Qiu Y; Song Y; Feng F; Feng J; Song Q; Jia Q; Wang J
    PLoS One; 2020; 15(7):e0235458. PubMed ID: 32645044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of Coronavirus Disease 2019 patients in Beijing, China.
    Cao Z; Li T; Liang L; Wang H; Wei F; Meng S; Cai M; Zhang Y; Xu H; Zhang J; Jin R
    PLoS One; 2020; 15(6):e0234764. PubMed ID: 32555674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience.
    Jiménez-Brítez G; Ruiz P; Soler X
    Med Clin (Barc); 2020 Nov; 155(9):410-411. PubMed ID: 32718713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.